2.36

1.67% -0.04

Achieve Life Sciences Inc (ACHV)

Overview News Price History Option Chain Financials Why ACHV Down? Discussions Forecast Stock Split

Achieve Life Sciences Inc stock is traded at $2.36, with a volume of 262.01K. It is down -1.67% in the last 24 hours and down -17.48% over the past month. Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Previous Close:

$2.40

Open:

$2.39

24h Volume:

262.01K

Relative Volume:

1.25

Market Cap:

$78.04M

Revenue:

Net Income/Loss:

$-32.94M

P/E Ratio:

-2.1261

EPS:

-1.11

Net Cash Flow:

$-24.95M

1W Performance:

+18.59%

1M Performance:

-17.48%

6M Performance:

-49.89%

1Y Performance:

-48.42%

1-Day Range:

$2.36

$2.48

1-Week Range:

$1.96

$2.63

52-Week Range:

$1.84

$5.59

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Name

Achieve Life Sciences Inc

Sector

Healthcare (1155)

Industry

Biotechnology (677)

Phone

425-686-1500

Address

22722 29TH DR. SE, SEATTLE, BC

Employee

Twitter

Next Earnings Date

2025-03-11

Latest SEC Filings

ACHV's Discussions on Twitter

Compare ACHV with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACHV Achieve Life Sciences Inc	2.36	78.04M	0	-32.94M	-24.95M	-1.11
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Initiated	Rodman & Renshaw	Buy
Sep-27-24	Initiated	Raymond James	Strong Buy
May-10-23	Reiterated	Maxim Group	Buy
Jun-23-21	Initiated	Oppenheimer	Outperform

Achieve Life Sciences Inc Stock (ACHV) Latest News

Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025

Apr 23, 2025

Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) - MSN

Apr 23, 2025

LPL Financial LLC Has $693,000 Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

Apr 23, 2025

Apr 22, 2025

Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial - Yahoo Finance

Apr 22, 2025

Apr 21, 2025

Cytisinicline shows promise for smoking cessation By Investing.com - Investing.com South Africa

Apr 21, 2025

Achieve Life Sciences Expects to File New Drug Application in US for Smoking Cessation Medication - marketscreener.com

Apr 21, 2025

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine | ACHV Stock News - GuruFocus

Apr 21, 2025

Achieve Life Sciences (ACHV) Confirms Cytisinicline Efficacy in Phase 3 ORCA-3 Trial | ACHV Stock News - GuruFocus

Apr 21, 2025

Cytisinicline’s FDA Path Ignites ACHV Stock: Could This Biotech Gem Soar on Smoking and Vaping Cessation Breakthroughs? - Own Snap

Apr 21, 2025

Achieve Life Sciences Announces Cytisinicline Phase 3 - GlobeNewswire

Apr 21, 2025

Breakthrough Smoking Cessation Drug Outperforms Existing Treatments in Major Phase 3 Trial, JAMA Reports - Stock Titan

Apr 21, 2025

Apr 12, 2025

157,519 Shares in Achieve Life Sciences, Inc. (NASDAQ:ACHV) Purchased by Raymond James Financial Inc. - MarketBeat

Apr 12, 2025

Apr 08, 2025

Raymond James Financial Inc. Invests $554,000 in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

Apr 08, 2025

Apr 01, 2025

ACHV Stock Touches 52-Week Low at $2.5 Amid Market Challenges - Investing.com UK

Apr 01, 2025

Mar 31, 2025

ACHIEVE LIFE SCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus

Mar 31, 2025

Mar 24, 2025

Contrasting Achieve Life Sciences (NASDAQ:ACHV) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Mar 24, 2025

Mar 23, 2025

Achieve Life Sciences (ACHV) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Mar 23, 2025

Mar 21, 2025

Insider Buying: Mark Oki Acquires Shares of Achieve Life Sciences Inc (ACHV) - GuruFocus

Mar 21, 2025

Mar 20, 2025